Interviews
Figuring Out The New Tech In Procurement
1. Can you give a short introduction of yourself?
My name is Stevanus Firman Kaligis, you can call me Steve. I am Global Leader of Procurement and my base is in Jakarta, Indonesia. I have a great interest in generating...
Interviews
How can the end-to-end services of CAI help pharmaceutical companies to establish high standards of operational productivity and overall efficiency
1) How can the end-to-end services of CAI help pharmaceutical companies to establish high standards of operational productivity and overall efficiency?
CAI India is rapidly growing, having trained and recruited 21 agents in the past four months. Our company focuses...
Interviews
ID determination of oligonucleotides
Fast, safe and efficient: the new Vetter ID determination of oligonucleotides.
Why is the analysis of oligonucleotides also a topic in the Analytical Science Laboratory (ASL)?
MELANIE ZERULLA-WERNITZ: Oligonucleotides (from Greek oligo = few) are oligomers which consist of few nucleotides....
Interviews
Vetter’s APAC Build-Up
APAC’s relevance to a company as big as Vetter, a world leader in Contract Development & Manufacturing, has been significant, more so in recent years due to China’s strong footprint in the region. To dig in more on what...
Interviews
Small Scale Batch Manufacturing: How small production quantities are growing in importance
Interview with Bernd Stauss, Senior Vice President Production/Engineering
1. What exactly is small scale batch manufacturing?
The developments in the pharmaceutical world are diverse. Today, drugs are often developed for specific patient groups, right down to the individual. In this context,...
Interviews
FDA DSCSA Pilot Program
Q&A: FDA DSCSA Recall Pilot Program lessons learned
Q: Can you update us on the FDA DSCSA Pilot Project programs TraceLink and its partners participated in now that the pilot projects have concluded?
Ans: The DSCSA pilot project,launched in 2019, intended...
Clinical Trials
A World Pharma Today exclusive with Jim Murphy, CEO, Greenphire
Who would have thought a pandemic in this modern era would cripple the world, the strongest economies would be shaken, and end up being so vulnerable despite having the most modern technologies and processes at our disposal. That being...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
